Home › Therapeutic areas › Ophthalmology › Ocular Surface Inflammation

Ocular Surface Inflammation (1 companies)

Companies with an active program in Ocular Surface Inflammation.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
KPRX Kiora Pharmaceuticals Ophthalmology Rare 1 Phase 3 $6.4M 4